Table 1.
Group | pCa50 | nH | Fmax (mN/mm2) | Fmin (mN/mm2) |
---|---|---|---|---|
WT | ||||
Pre‐Myk461 | 5.99±0.02 | 2.01±0.18 | 12.52±1.63 | 1.00±0.09 |
0.5 μmol/L Myk461 | 5.97±0.02 | 3.04±0.09a | 11.10±1.41 | 0.82±0.09 |
1.0 μmol/L Myk461 | 5.95±0.01 | 3.24±0.07a | 9.42±0.97 | 0.78±0.09 |
KO | ||||
Pre‐Myk461 | 6.05±0.02b | 2.24±0.21 | 12.21±1.29 | 1.13±0.17 |
0.5 μmol/L Myk461 | 6.02±0.01b | 2.66±0.12 | 10.41±1.28 | 1.29±0.15 |
1.0 μmol/L Myk461 | 6.01±0.02b | 2.91±0.25a | 11.10±1.70 | 1.38±0.18b |
Values are expressed as mean±SE of mean. Twelve skinned myocardial preparations (3 fibers each from 4 hearts) were used for both groups. Linear mixed model was used for data analysis with Tukey post hoc tests for multiple comparisons between groups of data. Fmax indicates Ca2+‐activated maximal force measured at pCa 4.5; Fmin, Ca2+‐independent force measured at pCa 9.0; KO, knockout; nH, cooperativity of force production; pCa50, myofilament Ca2+ sensitivity; WT, wild‐type.
Significantly different vs the corresponding pre‐Myk461 group (P<0.05).
Significantly different vs the corresponding WT group (P<0.05).